Terasaki Innovation Summit to focus on improving the technological, entrepreneurial implementation of personalized medicines

Terasaki Innovation Summit to focus on improving the technological, entrepreneurial implementation of personalized medicines

The Terasaki Institute for Biomedical Innovation (TIBI) will host the Terasaki Innovation Summit March 8-10, 2023 at the UCLA Meyer & Renee Luskin Center in Los Angeles. This inaugural event focuses on improving the technological and business translation of personalized medicines – bringing biomedical innovations from the laboratory into the real world.

With thought leaders and innovators discussing the future of biomedicine, bringing ideas from the bench to the bedside, and building and funding spin-off companies, the Terasaki Innovation Summit is essential for academics interested in commercializing their technologies and for industry participants interested in learning about the latest technologies in personalized medicine that are driving science to has to offer.

Too many technologies die because of the gap between industry and academia and the enormous obstacles that make licensing technologies challenging. The Terasaki Innovation Summit is focused on helping innovators bridge these gaps to bring new personalized and precise medicines to market and celebrate the legacy of our founder, who so successfully developed important organ transplant technologies that are still used by patients today.”

Ali Khademhosseini, Ph.D., Director and CEO of TIBI

Focuses on translating innovations in personalized medicine

At the inaugural Terasaki Innovation Summit, leading researchers will discuss the latest advances in micro- and nanotechnologies and applications in diagnostics, therapeutic drug delivery and regenerative medicine. In addition, key business leaders and experts in translation, innovation, venture investing, intellectual property and more will be on hand to share their knowledge and commercial experiences.

Biotechnology eBook

Compilation of the top interviews, articles and news from the last year. Download a free copy

Thought leaders will share their cutting-edge work and breakthrough innovations with keynote speakers including:

• Joseph DeSimone, Stanford-Professor, dessen Forschung sich auf die Entwicklung neuer Impfstoffplattformen für die Pädiatrie konzentriert

• Peter Diamandis, führender Unternehmer, Berater für technologische Innovation und Gründer von XPRIZE

• Robert Langer, MIT-Professor, produktiver Forscher, legendärer Pionier neuer biomedizinischer Technologien und Gründer von über vierzig Biotechnologieunternehmen

• Samir Mitragotri, Ph.D., renommierter Forscher auf den Gebieten Arzneimittelabgabe und biologische Barrieren

• Xiling Shen, Ph.D., Gründer und CEO von Xilis, Inc. und Chief Scientific Officer von TIBI

Introducing the Paul Terasaki and Hisako Terasaki Young Awards

The Terasaki Innovation Summit will also mark the debut of new awards for innovators, including the Paul Terasaki Award, which awards a participating innovator a $25,000 scholarship, and the Hisako Terasaki Young Innovator Travel Award, which recognizes young innovators in the field by reimbursing travel expenses.

Participation in the Terasaki Innovation Summit

The Terasaki Innovation Summit, taking place March 8-10, 2023 at UCLA's Luskin Conference Center in Los Angeles, promises to be a unique gathering of some of the most prominent names in the field of biomedical engineering and will provide a wealth of information and networking opportunities with others in the scientific community. Investors, industry and academics interested in participating can register at the following link, with discounts for students and academics: https://whova.com/portal/registration/tibi_202303/

Early bird registration ends November 18, 2022.

Source:

Terasaki Institute for Biomedical Innovation

.